Inflarx NV (NASDAQ:IFRX)

3.70
Delayed Data
As of Apr 16
 0.00 / 0.00%
Today’s Change
3.50
Today|||52-Week Range
9.70
-26.44%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$162.5M

Company Description

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a. Its products include IFX-1 and IFX-2. The company was founded by Niels Christoph Riedemann, Renfeng Guo and Nicolas Fulpius in December 2007 and is headquartered in Jena, Germany.

Contact Information

InflaRx NV
Winzerlaer Strasse 2
Jena Thueringen 07745
P:493641508180
Investor Relations:

Employees

Shareholders

Other institutional43.50%
Mutual fund holders2.53%
Individual stakeholders--

Top Executives

Niels Christoph RiedemannChief Executive Officer & Executive Director
Thomas TaapkenChief Financial Officer
Renfeng GuoExecutive Director & Chief Scientific Officer
Maria HabelHead-Research & Development
Korinna PilzGlobal Head-Clinical Research & Development